Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy

Judge, D. P., Alexander, K. M., Cappelli, F., Fontana, M., Garcia-Pavia, P., Gibbs, S. D. J., Grogan, M., Hanna, M., Masri, A., Maurer, M. S., Obici, L., Soman, P., Cao, X., Lystig, T., Tamby, J.-F., Siddhanti, S., Castaño, A., Katz, L., Fox, J. C., … Gillmore, J. D. (2025). Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy. Journal of the American College of Cardiology, 85(10), 1003–1014. https://doi.org/10.1016/j.jacc.2024.11.042
Authors:
Daniel P Judge
Kevin M Alexander
Francesco Cappelli
Marianna Fontana
Pablo Garcia-Pavia
Simon D J Gibbs
Martha Grogan
Mazen Hanna
Ahmad Masri
Mathew S Maurer
Laura Obici
Prem Soman
Xiaofan Cao
Ted Lystig
Jean-François Tamby
Suresh Siddhanti
Adam Castaño
Leonid Katz
Jonathan C Fox
Kenneth W Mahaffey
Julian D Gillmore
Affiliated Authors:
Mathew S Maurer
Author Keywords:
acoramidis
all-cause mortality
attr-cm
cardiovascular-related hospitalization
transthyretin
Publication Type:
Article
Unique ID:
10.1016/j.jacc.2024.11.042
PMID:
Publication Date:
Data Source:
PubMed

Record Created: